1. Home
  2. PTLE vs ADXN Comparison

PTLE vs ADXN Comparison

Compare PTLE & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PTLE

PTL LTD Ordinary Shares

HOLD

Current Price

$0.13

Market Cap

9.8M

Sector

Energy

ML Signal

HOLD

Logo Addex Therapeutics Ltd

ADXN

Addex Therapeutics Ltd

N/A

Current Price

$8.33

Market Cap

10.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PTLE
ADXN
Founded
2013
2002
Country
Singapore
Switzerland
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.8M
10.3M
IPO Year
2024
N/A

Fundamental Metrics

Financial Performance
Metric
PTLE
ADXN
Price
$0.13
$8.33
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
742.9K
8.1K
Earning Date
11-03-2025
12-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$91,415,732.00
$198,824.00
Revenue This Year
N/A
$86.57
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.10
$6.51
52 Week High
$14.55
$12.05

Technical Indicators

Market Signals
Indicator
PTLE
ADXN
Relative Strength Index (RSI) 56.05 52.53
Support Level $0.10 $7.00
Resistance Level $0.12 $10.43
Average True Range (ATR) 0.01 0.53
MACD 0.00 0.06
Stochastic Oscillator 66.03 38.78

Price Performance

Historical Comparison
PTLE
ADXN

About PTLE PTL LTD Ordinary Shares

PTL Ltd is a holding company. Through its subsidiaries, it is an established bunkering facilitator providing marine fuel logistics services for vessel refuelling, serving the Asia Pacific market. The company's services mainly involve facilitating with its suppliers to supply fuel for the use by the customers' vessels at various ports along their voyages in the Asia Pacific region; arranging vessel refuelling activities at competitive pricing to the customers; offering trade credit to the customers for vessel refuelling; handling unforeseeable circumstances faced by the customers and providing contingency solutions to the customers on time; and handling disputes, mainly concerning quality and quantity issues on marine fuel. The company derives its maximum revenue from Hong Kong.

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.

Share on Social Networks: